For example, although we found that CELF2 expression was associated with the abundance of TIIC infiltration in BRCA and LUSC patients, we could not conclude whether CELF2 directly affected patient survival through immune infiltration. The gene discussed is CELF2; the disease is invasive breast carcinoma.